Rani Therapeutics Holdings Inc (NASDAQ: RANI) kicked off on Friday, down -11.01% from the previous trading day, before settling in for the closing price of $2.27. Over the past 52 weeks, RANI has traded in a range of $0.39-$3.87.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 4.78%. While this was happening, its average annual earnings per share was recorded 57.04%. With a float of $40.07 million, this company’s outstanding shares have now reached $47.94 million.
Rani Therapeutics Holdings Inc (RANI) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Rani Therapeutics Holdings Inc is 16.34%, while institutional ownership is 32.91%. The most recent insider transaction that took place on Oct 23 ’25, was worth 1,260,417. In this transaction Director of this company bought 2,083,334 shares at a rate of $0.60, taking the stock ownership to the 2,083,334 shares. Before that another transaction happened on Oct 21 ’25, when Company’s 10% Owner sold 4,000,000 for $2.77, making the entire transaction worth $11,074,000. This insider now owns 2,379,194 shares in total.
Rani Therapeutics Holdings Inc (RANI) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.16 earnings per share (EPS), higher than consensus estimate (set at -0.23) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.04% during the next five years compared to 4.78% growth over the previous five years of trading.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
Take a look at Rani Therapeutics Holdings Inc’s (RANI) current performance indicators. Last quarter, stock had a quick ratio of 0.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 120.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.29 in one year’s time.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
The latest stats from [Rani Therapeutics Holdings Inc, RANI] show that its last 5-days average volume of 17.08 million was superior to 5.95 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 70.45%.
During the past 100 days, Rani Therapeutics Holdings Inc’s (RANI) raw stochastic average was set at 46.88%, which indicates a significant increase from 24.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.56 in the past 14 days, which was higher than the 0.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.00, while its 200-day Moving Average is $0.96. Now, the first resistance to watch is $2.12. This is followed by the second major resistance level at $2.21. The third major resistance level sits at $2.36. If the price goes on to break the first support level at $1.88, it is likely to go to the next support level at $1.73. Assuming the price breaks the second support level, the third support level stands at $1.64.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Key Stats
The company with the Market Capitalisation of 145.17 million has total of 71,869K Shares Outstanding. Its annual sales at the moment are 1,030 K in contrast with the sum of -30,020 K annual income. Company’s last quarter sales were recorded 170 K and last quarter income was -7,260 K.
